Fig. 1From: Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center studyPatient selection flowchart. A total of thirty-five patients were included in the final cohortBack to article page